990 related articles for article (PubMed ID: 17202596)
1. Signaling pathways implicated in hematopoietic progenitor cell proliferation and differentiation.
Bugarski D; Krstic A; Mojsilovic S; Vlaski M; Petakov M; Jovcic G; Stojanovic N; Milenkovic P
Exp Biol Med (Maywood); 2007 Jan; 232(1):156-63. PubMed ID: 17202596
[TBL] [Abstract][Full Text] [Related]
2. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
3. Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors.
Miller BA; Lipton JM; Linch DC; Burakoff SJ; Nathan DG
J Cell Physiol; 1985 Apr; 123(1):25-32. PubMed ID: 2857726
[TBL] [Abstract][Full Text] [Related]
4. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
Bilgeri R; Petzer AL; Zilian U; Geisen FH; Schirmer M; Haun M; Konwalinka G
Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026
[TBL] [Abstract][Full Text] [Related]
5. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
[TBL] [Abstract][Full Text] [Related]
6. Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program.
Valtieri M; Tocci A; Gabbianelli M; Luchetti L; Masella B; Vitelli L; Botta R; Testa U; Condorelli GL; Peschle C
Cancer Res; 1998 Feb; 58(3):562-9. PubMed ID: 9458106
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development.
Wang CQ; Udupa KB; Lipschitz DA
J Cell Physiol; 1995 Jan; 162(1):134-8. PubMed ID: 7814445
[TBL] [Abstract][Full Text] [Related]
8. Distinct circadian time structures characterize myeloid and erythroid progenitor and multipotential cell clonogenicity as well as marrow precursor proliferation dynamics.
Wood PA; Hrushesky WJ; Klevecz R
Exp Hematol; 1998 Jun; 26(6):523-33. PubMed ID: 9620286
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood progenitor cell mobilisation alters myeloid, but not erythroid, progenitor cell self-renewal kinetics.
Marley SB; Lewis JL; Zheng B; Davidson RJ; Davis JG; McDonald C; Alenzi FQ; Goldman JM; Gordon MY
Bone Marrow Transplant; 2001 Feb; 27(3):241-8. PubMed ID: 11277171
[TBL] [Abstract][Full Text] [Related]
10. The Mpl-ligand is involved in the growth-promoting activity of the murine stromal cell line MS-5 on ES cell-derived hematopoiesis.
Mitjavila MT; Filippi MD; Cohen-Solal K; Le Pesteur F; Vainchenker W; Sainteny F
Exp Hematol; 1998 Feb; 26(2):124-34. PubMed ID: 9472802
[TBL] [Abstract][Full Text] [Related]
11. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
Scheding S; Media JE; Nakeff A
Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
[TBL] [Abstract][Full Text] [Related]
12. Ineffective erythropoiesis in mutant mice with deficient pyruvate kinase activity.
Aizawa S; Harada T; Kanbe E; Tsuboi I; Aisaki K; Fujii H; Kanno H
Exp Hematol; 2005 Nov; 33(11):1292-8. PubMed ID: 16263413
[TBL] [Abstract][Full Text] [Related]
13. Integrin engagement-induced inhibition of human myelopoiesis is mediated by proline-rich tyrosine kinase 2 gene products.
Dylla SJ; Deyle DR; Theunissen K; Padurean AM; Verfaillie CM
Exp Hematol; 2004 Apr; 32(4):365-74. PubMed ID: 15050747
[TBL] [Abstract][Full Text] [Related]
14. The effect of natural killer cells on the development of syngeneic hematopoietic progenitors.
Holmberg LA; Miller BA; Ault KA
J Immunol; 1984 Dec; 133(6):2933-9. PubMed ID: 6436368
[TBL] [Abstract][Full Text] [Related]
15. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM
Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
[TBL] [Abstract][Full Text] [Related]
16. Effects of erythroid differentiation factor (EDF) on proliferation and differentiation of human hematopoietic progenitors.
Nakao K; Kosaka M; Saito S
Exp Hematol; 1991 Dec; 19(11):1090-5. PubMed ID: 1752318
[TBL] [Abstract][Full Text] [Related]
17. Specific binding of interferon-gamma to high affinity receptors on human erythroid colony-forming cells.
Taniguchi S; Dai CH; Krantz SB
Exp Hematol; 1997 Mar; 25(3):193-8. PubMed ID: 9091293
[TBL] [Abstract][Full Text] [Related]
18. Opposing effects of PI3 kinase pathway activation on human myeloid and erythroid progenitor cell proliferation and differentiation in vitro.
Lewis JL; Marley SB; Ojo M; Gordon MY
Exp Hematol; 2004 Jan; 32(1):36-44. PubMed ID: 14725899
[TBL] [Abstract][Full Text] [Related]
19. Notch1 activation reduces proliferation in the multipotent hematopoietic progenitor cell line FDCP-mix through a p53-dependent pathway but Notch1 effects on myeloid and erythroid differentiation are independent of p53.
Henning K; Heering J; Schwanbeck R; Schroeder T; Helmbold H; Schäfer H; Deppert W; Kim E; Just U
Cell Death Differ; 2008 Feb; 15(2):398-407. PubMed ID: 18049480
[TBL] [Abstract][Full Text] [Related]
20. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
